Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,427,712
+$531,339 QoQ
Shares Held
17,434
+9.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#1,705
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ranch Capital Advisors Inc. holds $19,506,059 across 8 Drug Manufacturers - General names. JNJ ranks #1 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
17,434 | $4,427,712 | |
| 2 | AMGN |
Amgen Inc
|
12,108 | $4,384,548 | |
| 3 | ABBV |
AbbVie Inc.
|
16,101 | $4,051,655 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
29,324 | $3,704,794 | |
| 5 | PFE |
Pfizer Inc
|
85,339 | $2,054,963 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,727 | $329,989 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,404 | $308,914 | |
| 8 | LLY |
ELI LILLY & Co
|
203 | $243,484 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,427,712 | 17,434 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,896,373 | 15,940 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,180,821 | 15,370 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,738,467 | 14,769 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,082,440 | 13,633 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,190,580 | 13,209 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $497,782 | 3,442 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $563,968 | 3,480 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $536,553 | 3,671 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,724,903 | 10,904 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,690,754 | 10,787 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,666,369 | 10,699 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,766,429 | 10,672 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,663,460 | 10,732 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,863,127 | 10,547 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,709,072 | 10,462 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,802,436 | 10,154 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,743,234 | 9,836 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,639,705 | 9,585 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,536,026 | 9,511 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,447,240 | 8,785 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,756,079 | 10,685 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,510,218 | 9,596 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,382,499 | 9,286 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,313,062 | 9,337 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,123,259 | 8,566 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||